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I have read with interest a recent report by 
Shao and coworkers on the putative role of 
PON1 in ischemic stroke [1]. In their report, the 
authors refute an association of a missense 
substitution on the phenotype under study 
based on earlier research. It appears unlikely, 
however, that the results can be upheld in the 
present form.
To begin with, study inclusion criteria are not 
respected. Contrary to the claims made, Hardy-
Weinberg equilibrium is violated in controls 
(see Aydin et al., 2006 [2]) and studies without 
genotype details were included (Wang et al. [3], 
Zhang et al. [4], and Pasdar et al. [5]). Major 
flaws in the original publications were over-
seen, e.g. the muddling of cases and controls 
by Zhang et al., 2013 [4], or striking discrepan-
cies in minor allele frequencies (e.g. Aydin et 
al., 2006 [2]) that should have led to an exclu-
sion from pooling the respective genotype data. 
Likewise, obvious typographical errors that 
interfere with allele specifications in another 
study (Moghtaderi et al., 2011 [6]) were toler-
ated and results were arbitrarily modified a 
posteriori. Sample size is also incorrect in sev-
eral studies (e.g., Imai et al., 2000 [7], Ranade 
et al., 2005 [8]), reaching the three-fold of the 
original figure in one study (Slowik et al., 2007 
[9]).
Misclassification of some 2,634 Chinese sub-
jects (Wang et al., 2009 [3]) as ‘Caucasians’ 
casts further doubt on the validity of results for 
Asian and non-Asian populations. The odds 
ratios shown deviate markedly from those pub-
lished (e.g., for the additive model, a risk-lower-
ing OR is given whereas the original paper cites 
a risk-enhancing OR [10] and vice versa [3]). 
Finally, the meta-analysis refers to subsamples 
with large vessel disease only in some studies 
[9] but includes subsamples with small vessel 
disease and large vessel disease in others [5]. 
On the whole, the report by Shao and col-
leagues provides a blurred view of effects that 
may be attributable to a paraoxonase variant in 
ischemic stroke and is best reconducted.
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